Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous

NCT03042260 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: Trimethoprim-Sulfamethoxazole
DRUG: Placebo Oral Tablet

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Collaborators

[object Object]